Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AMGN | GILD | CELG | VRTX |
| Company | Cara Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6610 | 273.45 | 67.47 | 108.01 | 402.44 |
| High | 0.6774 | 274.35 | 67.90 | 108.59 | 403.88 |
| Low | 0.6501 | 267.55 | 65.32 | 107.27 | 393.00 |
| Last | 0.6690 | 268.34 | 65.82 | 108.24 | 394.46 |
| Change | -0.0026 | -4.67 | -1.26 | +0.11 | -6.30 |
| % Change | -0.39% | -1.71% | -1.88% | +0.10% | -1.57% |
| Volume | 55,434 | 402,901 | 2,943,357 | 191,230,496 | 214,957 |
| 20-Day Average Volume | 347,181 | 2,076,602 | 6,213,982 | 16,188,930 | 933,529 |
| Previous Close | 0.6716 | 273.01 | 67.08 | 108.13 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7837 | 270.64 | 68.70 | 108.17 | 402.12 |
| 20-Day Raw Stochastic | 12.44% | 26.90% | 0.00% | 63.25% | 9.49% |
| 20-Day Relative Strength | 42.47% | 43.79% | 28.94% | 64.69% | 40.30% |
| Weighted Alpha | -77.39 | +8.44 | -23.29 | +46.30 | +13.35 |
| Today's Opinion | 72% Sell | 72% Sell | 100% Sell | 100% Buy | 8% Sell |
| Previous Opinion | 72% Sell | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 48% Sell | 24% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.61% since 04/18/24 | +2.07% since 04/18/24 | -0.94% since 04/18/24 | -1.97% since 11/13/19 | +0.11% since 04/18/24 |
| Low | 0.6500 on 04/22/24 | 260.68 on 04/19/24 | 65.54 on 04/25/24 | 107.27 on 11/20/19 | 391.25 on 04/19/24 |
| High | 0.7394 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -18.04% since 03/25/24 | -4.50% since 03/25/24 | -9.70% since 03/25/24 | +5.14% since 10/18/19 | -5.32% since 03/25/24 |
| Low | 0.6311 on 04/16/24 | 260.68 on 04/19/24 | 65.54 on 04/25/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 0.9600 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +19.02% since 01/25/24 | -13.56% since 01/25/24 | -18.31% since 01/25/24 | +13.63% since 08/20/19 | -8.39% since 01/25/24 |
| Low | 0.5150 on 02/08/24 | 260.68 on 04/19/24 | 65.54 on 04/25/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 1.1500 on 03/04/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -45.37% since 10/25/23 | -1.46% since 10/25/23 | -16.39% since 10/25/23 | +14.14% since 05/20/19 | +8.50% since 10/25/23 |
| Low | 0.5000 on 01/25/24 | 249.70 on 10/31/23 | 65.54 on 04/25/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 1.4000 on 11/06/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 36,714 | 146,436,016 | 83,519,768 | 77,035,920 | 103,580,040 |
| Shares Outstanding, K | 54,667 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 20,970,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -118,510,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,000,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -32,340,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.70 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 03/04/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 30.13 |